COVID-19 vaccine candidates secure funds; Lysol gets EPA nod
7:31am PDT - July 7th, 2020 novavax stock - ABC NewsNovavax has received $1.6 billion from the federal government to complete late-stage clinical development; establish large-scale manufacturing; and deliver 100 million doses of NVX‑CoV2373, its COVID-19 vaccine candidate, as early as late 2020